The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was named:
"Fibronectin, type II, collagen-binding
".
FunFam 1: Fibronectin 1a isoform 1
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 67 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
24 |
P02751 (/IPI)
P02751 (/IPI)
P04937 (/IPI)
P04937 (/IPI)
P07589 (/IPI)
P07589 (/IPI)
P08253 (/IPI)
P08253 (/IPI)
P08253 (/IPI)
P08253 (/IPI)
(14 more) |
Metalloendopeptidase activity GO:0004222
Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
|
15 |
O18733 (/ISS)
O18733 (/ISS)
O18733 (/ISS)
P41245 (/ISS)
P41245 (/ISS)
P41245 (/ISS)
P41246 (/ISS)
P41246 (/ISS)
P41246 (/ISS)
P50282 (/ISS)
(5 more) |
Metallopeptidase activity GO:0008237
Catalysis of the hydrolysis of peptide bonds by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
|
13 |
P08253 (/IDA)
P08253 (/IDA)
P08253 (/IDA)
P08253 (/IDA)
P14780 (/IDA)
P14780 (/IDA)
P14780 (/IDA)
P41245 (/IDA)
P41245 (/IDA)
P41245 (/IDA)
(3 more) |
Metalloendopeptidase activity GO:0004222
Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
|
12 |
P14780 (/IDA)
P14780 (/IDA)
P14780 (/IDA)
P33434 (/IDA)
P33434 (/IDA)
P33434 (/IDA)
P33434 (/IDA)
P41245 (/IDA)
P41245 (/IDA)
P41245 (/IDA)
(2 more) |
Integrin binding GO:0005178
Interacting selectively and non-covalently with an integrin.
|
12 |
B0S602 (/IDA)
B0S602 (/IDA)
B3DGZ1 (/IDA)
B3DGZ1 (/IDA)
F1RBP8 (/IDA)
F1RBP8 (/IDA)
O93405 (/IDA)
O93405 (/IDA)
O93406 (/IDA)
O93406 (/IDA)
(2 more) |
Signaling receptor activity GO:0038023
Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
|
11 |
F1M495 (/ISS)
F1PGC5 (/ISS)
F6Y1A5 (/ISS)
F7CUS6 (/ISS)
G1L1S3 (/ISS)
G1PP42 (/ISS)
G1QLJ9 (/ISS)
P49259 (/ISS)
P49260 (/ISS)
Q5R880 (/ISS)
(1 more) |
Metalloendopeptidase activity GO:0004222
Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
|
10 | P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P14780 (/TAS) P14780 (/TAS) P14780 (/TAS) P50282 (/TAS) P50282 (/TAS) P50282 (/TAS) |
Integrin binding GO:0005178
Interacting selectively and non-covalently with an integrin.
|
10 | B0S602 (/IGI) B0S602 (/IGI) B3DGZ1 (/IGI) B3DGZ1 (/IGI) F1RBP8 (/IGI) F1RBP8 (/IGI) O93405 (/IGI) O93405 (/IGI) O93406 (/IGI) O93406 (/IGI) |
Phospholipase binding GO:0043274
Interacting selectively and non-covalently with any phospholipase, enzymes that catalyze of the hydrolysis of a glycerophospholipid.
|
10 | F1M495 (/ISS) F1PGC5 (/ISS) F6Y1A5 (/ISS) F7CUS6 (/ISS) G1L1S3 (/ISS) G1PP42 (/ISS) G1QLJ9 (/ISS) P49259 (/ISS) P49260 (/ISS) Q5R880 (/ISS) |
Extracellular matrix structural constituent GO:0005201
The action of a molecule that contributes to the structural integrity of the extracellular matrix.
|
8 | F1SS24 (/RCA) F1SS24 (/RCA) P02751 (/RCA) P02751 (/RCA) P11276 (/RCA) P11276 (/RCA) Q3UGY5 (/RCA) Q3UGY5 (/RCA) |
Peptidase activity GO:0008233
Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
|
8 | P33436 (/IDA) P33436 (/IDA) P41245 (/IDA) P41245 (/IDA) P41245 (/IDA) P50282 (/IDA) P50282 (/IDA) P50282 (/IDA) |
Fibronectin binding GO:0001968
Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
|
7 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Serine-type endopeptidase activity GO:0004252
Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
|
7 | P08253 (/EXP) P08253 (/EXP) P08253 (/EXP) P08253 (/EXP) P14780 (/EXP) P14780 (/EXP) P14780 (/EXP) |
Serine-type endopeptidase activity GO:0004252
Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
|
7 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Peptidase activity GO:0008233
Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
|
7 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Metallopeptidase activity GO:0008237
Catalysis of the hydrolysis of peptide bonds by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
|
7 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Zinc ion binding GO:0008270
Interacting selectively and non-covalently with zinc (Zn) ions.
|
7 | P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P14780 (/TAS) P14780 (/TAS) P14780 (/TAS) |
Fibronectin binding GO:0001968
Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
|
5 | P33436 (/IPI) P33436 (/IPI) P50282 (/IPI) P50282 (/IPI) P50282 (/IPI) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
5 | P02751 (/IPI) P02751 (/IPI) P14780 (/IPI) P14780 (/IPI) P14780 (/IPI) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
5 | P11276 (/ISO) P11276 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Protease binding GO:0002020
Interacting selectively and non-covalently with any protease or peptidase.
|
4 | P02751 (/IPI) P02751 (/IPI) P04937 (/IPI) P04937 (/IPI) |
Serine-type endopeptidase activity GO:0004252
Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
|
4 | P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) |
Disordered domain specific binding GO:0097718
Interacting selectively and non-covalently with a disordered domain of a protein.
|
4 | P02751 (/IPI) P02751 (/IPI) P07589 (/IPI) P07589 (/IPI) |
Endopeptidase activity GO:0004175
Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain.
|
3 | P14780 (/IDA) P14780 (/IDA) P14780 (/IDA) |
Endopeptidase activity GO:0004175
Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Metalloendopeptidase activity GO:0004222
Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Collagen binding GO:0005518
Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
|
3 | P14780 (/TAS) P14780 (/TAS) P14780 (/TAS) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
3 | P50282 (/IDA) P50282 (/IDA) P50282 (/IDA) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Protease binding GO:0002020
Interacting selectively and non-covalently with any protease or peptidase.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Metalloendopeptidase activity GO:0004222
Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
|
2 | Q90611 (/IMP) Q90611 (/IMP) |
Transmembrane signaling receptor activity GO:0004888
Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction.
|
2 | Q61830 (/IDA) Q61830 (/IDA) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
2 | P02751 (/IPI) P02751 (/IPI) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Integrin binding GO:0005178
Interacting selectively and non-covalently with an integrin.
|
2 | P02751 (/IMP) P02751 (/IMP) |
Integrin binding GO:0005178
Interacting selectively and non-covalently with an integrin.
|
2 | P02751 (/IPI) P02751 (/IPI) |
Integrin binding GO:0005178
Interacting selectively and non-covalently with an integrin.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Extracellular matrix structural constituent GO:0005201
The action of a molecule that contributes to the structural integrity of the extracellular matrix.
|
2 | P02751 (/HDA) P02751 (/HDA) |
Extracellular matrix structural constituent GO:0005201
The action of a molecule that contributes to the structural integrity of the extracellular matrix.
|
2 | P02751 (/ISS) P02751 (/ISS) |
Extracellular matrix structural constituent GO:0005201
The action of a molecule that contributes to the structural integrity of the extracellular matrix.
|
2 | P04937 (/TAS) P04937 (/TAS) |
Collagen binding GO:0005518
Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
|
2 | P02751 (/NAS) P02751 (/NAS) |
Mannose binding GO:0005537
Interacting selectively and non-covalently with mannose, a monosaccharide hexose, stereoisomeric with glucose, that occurs naturally only in polymerized forms called mannans.
|
2 | Q61830 (/IDA) Q61830 (/IDA) |
Protein C-terminus binding GO:0008022
Interacting selectively and non-covalently with a protein C-terminus, the end of any peptide chain at which the 1-carboxyl function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
|
2 | P02751 (/IPI) P02751 (/IPI) |
Protein C-terminus binding GO:0008022
Interacting selectively and non-covalently with a protein C-terminus, the end of any peptide chain at which the 1-carboxyl function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Heparin binding GO:0008201
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
|
2 | P02751 (/NAS) P02751 (/NAS) |
Metallopeptidase activity GO:0008237
Catalysis of the hydrolysis of peptide bonds by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
|
2 | P33436 (/TAS) P33436 (/TAS) |
Peptidase activator activity GO:0016504
Binds to and increases the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds.
|
2 | P11276 (/IDA) P11276 (/IDA) |
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
|
2 | P02751 (/IPI) P02751 (/IPI) |
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Cargo receptor activity GO:0038024
Binding specifically to a substance (cargo) to deliver it to a transport vesicle. Cargo receptors span a membrane (either the plasma membrane or a vesicle membrane), binding simultaneously to cargo molecules and coat adaptors, to efficiently recruit soluble proteins to nascent vesicles.
|
2 | Q61830 (/ISO) Q61830 (/ISO) |
Cargo receptor activity GO:0038024
Binding specifically to a substance (cargo) to deliver it to a transport vesicle. Cargo receptors span a membrane (either the plasma membrane or a vesicle membrane), binding simultaneously to cargo molecules and coat adaptors, to efficiently recruit soluble proteins to nascent vesicles.
|
2 | Q61830 (/ISS) Q61830 (/ISS) |
Proteoglycan binding GO:0043394
Interacting selectively and non-covalently with a proteoglycan, any glycoprotein in which the carbohydrate units are glycosaminoglycans.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Proteoglycan binding GO:0043394
Interacting selectively and non-covalently with a proteoglycan, any glycoprotein in which the carbohydrate units are glycosaminoglycans.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Mercury ion binding GO:0045340
Interacting selectively and non-covalently with mercury (Hg) ions.
|
2 | P04937 (/IDA) P04937 (/IDA) |
Mercury ion binding GO:0045340
Interacting selectively and non-covalently with mercury (Hg) ions.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Chaperone binding GO:0051087
Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
|
2 | P02751 (/IPI) P02751 (/IPI) |
Chaperone binding GO:0051087
Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Disordered domain specific binding GO:0097718
Interacting selectively and non-covalently with a disordered domain of a protein.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Collagen binding GO:0005518
Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
|
1 | Q9UBG0 (/IDA) |
Collagen binding GO:0005518
Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
|
1 | Q4TU93 (/IPI) |
Collagen binding GO:0005518
Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
|
1 | Q64449 (/ISO) |
Mannose binding GO:0005537
Interacting selectively and non-covalently with mannose, a monosaccharide hexose, stereoisomeric with glucose, that occurs naturally only in polymerized forms called mannans.
|
1 | P22897 (/TAS) |
Carbohydrate binding GO:0030246
Interacting selectively and non-covalently with any carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates.
|
1 | Q64449 (/ISO) |
Signaling receptor activity GO:0038023
Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
|
1 | Q62028 (/ISO) |
Cargo receptor activity GO:0038024
Binding specifically to a substance (cargo) to deliver it to a transport vesicle. Cargo receptors span a membrane (either the plasma membrane or a vesicle membrane), binding simultaneously to cargo molecules and coat adaptors, to efficiently recruit soluble proteins to nascent vesicles.
|
1 | P22897 (/IDA) |
Phospholipase binding GO:0043274
Interacting selectively and non-covalently with any phospholipase, enzymes that catalyze of the hydrolysis of a glycerophospholipid.
|
1 | Q62028 (/IPI) |
Phospholipase binding GO:0043274
Interacting selectively and non-covalently with any phospholipase, enzymes that catalyze of the hydrolysis of a glycerophospholipid.
|
1 | Q62028 (/ISO) |
There are 304 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Somitogenesis GO:0001756
The formation of mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
|
18 |
A0A0R4IDI3 (/IGI)
A0A0R4IDI3 (/IGI)
A2CEW3 (/IGI)
A2CEW3 (/IGI)
B0S602 (/IGI)
B0S602 (/IGI)
B3DGZ1 (/IGI)
B3DGZ1 (/IGI)
F1RBP8 (/IGI)
F1RBP8 (/IGI)
(8 more) |
Somitogenesis GO:0001756
The formation of mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
|
18 |
A0A0R4IDI3 (/IMP)
A0A0R4IDI3 (/IMP)
A2CEW3 (/IMP)
A2CEW3 (/IMP)
B0S602 (/IMP)
B0S602 (/IMP)
B3DGZ1 (/IMP)
B3DGZ1 (/IMP)
F1RBP8 (/IMP)
F1RBP8 (/IMP)
(8 more) |
Heart field specification GO:0003128
The process that results in the delineation of a specific region of the lateral mesoderm into the area in which the heart will develop.
|
18 |
A0A0R4IDI3 (/IGI)
A0A0R4IDI3 (/IGI)
A2CEW3 (/IGI)
A2CEW3 (/IGI)
B0S602 (/IGI)
B0S602 (/IGI)
B3DGZ1 (/IGI)
B3DGZ1 (/IGI)
F1RBP8 (/IGI)
F1RBP8 (/IGI)
(8 more) |
Proteolysis GO:0006508
The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
|
15 |
O18733 (/ISS)
O18733 (/ISS)
O18733 (/ISS)
P41245 (/ISS)
P41245 (/ISS)
P41245 (/ISS)
P41246 (/ISS)
P41246 (/ISS)
P41246 (/ISS)
P50282 (/ISS)
(5 more) |
Proteolysis GO:0006508
The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
|
12 |
P08253 (/IDA)
P08253 (/IDA)
P08253 (/IDA)
P08253 (/IDA)
P14780 (/IDA)
P14780 (/IDA)
P14780 (/IDA)
P33436 (/IDA)
P33436 (/IDA)
P50282 (/IDA)
(2 more) |
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
|
12 |
F1M495 (/ISS)
F1PGC5 (/ISS)
F6Y1A5 (/ISS)
F7CUS6 (/ISS)
G1L1S3 (/ISS)
G1PP42 (/ISS)
G1QLJ9 (/ISS)
P49259 (/ISS)
P49260 (/ISS)
Q5R880 (/ISS)
(2 more) |
Hematopoietic stem cell migration GO:0035701
The orderly movement of a hematopoietic stem cell from one site to another. A hematopoietic stem cell is a cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system.
|
12 |
F1QC76 (/IMP)
F1QC76 (/IMP)
F1QC76 (/IMP)
F8QXP1 (/IMP)
F8QXP1 (/IMP)
Q6DG10 (/IMP)
Q6DG10 (/IMP)
Q7SZM5 (/IMP)
Q7SZM5 (/IMP)
Q7T317 (/IMP)
(2 more) |
Cytokine production GO:0001816
The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
11 |
F1M495 (/ISS)
F1PGC5 (/ISS)
F6Y1A5 (/ISS)
F7CUS6 (/ISS)
G1L1S3 (/ISS)
G1PP42 (/ISS)
G1QLJ9 (/ISS)
P49259 (/ISS)
P49260 (/ISS)
Q5R880 (/ISS)
(1 more) |
Positive regulation of DNA damage response, signal transduction by p53 class mediator GO:0043517
Any process that activates, maintains or increases the rate of the cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage.
|
11 |
F1M495 (/ISS)
F1PGC5 (/ISS)
F6Y1A5 (/ISS)
F7CUS6 (/ISS)
G1L1S3 (/ISS)
G1PP42 (/ISS)
G1QLJ9 (/ISS)
P49259 (/ISS)
P49260 (/ISS)
Q5R880 (/ISS)
(1 more) |
Reactive oxygen species metabolic process GO:0072593
The chemical reactions and pathways involving a reactive oxygen species, any molecules or ions formed by the incomplete one-electron reduction of oxygen. They contribute to the microbicidal activity of phagocytes, regulation of signal transduction and gene expression, and the oxidative damage to biopolymers.
|
11 |
F1M495 (/ISS)
F1PGC5 (/ISS)
F6Y1A5 (/ISS)
F7CUS6 (/ISS)
G1L1S3 (/ISS)
G1PP42 (/ISS)
G1QLJ9 (/ISS)
P49259 (/ISS)
P49260 (/ISS)
Q5R880 (/ISS)
(1 more) |
Positive regulation of arachidonic acid secretion GO:0090238
Any process that increases the rate, frequency, or extent of arachidonic acid secretion, the controlled release of arachidonic acid from a cell or a tissue.
|
11 |
F1M495 (/ISS)
F1PGC5 (/ISS)
F6Y1A5 (/ISS)
F7CUS6 (/ISS)
G1L1S3 (/ISS)
G1PP42 (/ISS)
G1QLJ9 (/ISS)
P49259 (/ISS)
P49260 (/ISS)
Q13018 (/ISS)
(1 more) |
Replicative senescence GO:0090399
A cell aging process associated with the dismantling of a cell as a response to telomere shortening and/or cellular aging.
|
11 |
F1M495 (/ISS)
F1PGC5 (/ISS)
F6Y1A5 (/ISS)
F7CUS6 (/ISS)
G1L1S3 (/ISS)
G1PP42 (/ISS)
G1QLJ9 (/ISS)
P49259 (/ISS)
P49260 (/ISS)
Q5R880 (/ISS)
(1 more) |
Oxidative stress-induced premature senescence GO:0090403
A cellular senescence process associated with the dismantling of a cell as a response to oxidative stress, e.g. high levels of reactive oxygen species, such as superoxide anions, hydrogen peroxide, and hydroxyl radicals.
|
11 |
F1M495 (/ISS)
F1PGC5 (/ISS)
F6Y1A5 (/ISS)
F7CUS6 (/ISS)
G1L1S3 (/ISS)
G1PP42 (/ISS)
G1QLJ9 (/ISS)
P49259 (/ISS)
P49260 (/ISS)
Q5R880 (/ISS)
(1 more) |
Somite specification GO:0001757
The process in which individual somites establish identity during embryogenesis.
|
10 | B0S602 (/IGI) B0S602 (/IGI) B3DGZ1 (/IGI) B3DGZ1 (/IGI) F1RBP8 (/IGI) F1RBP8 (/IGI) O93405 (/IGI) O93405 (/IGI) O93406 (/IGI) O93406 (/IGI) |
Cell migration involved in sprouting angiogenesis GO:0002042
The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels involved in sprouting angiogenesis.
|
10 | B0S602 (/IMP) B0S602 (/IMP) B3DGZ1 (/IMP) B3DGZ1 (/IMP) F1RBP8 (/IMP) F1RBP8 (/IMP) O93405 (/IMP) O93405 (/IMP) O93406 (/IMP) O93406 (/IMP) |
Lens morphogenesis in camera-type eye GO:0002089
The process in which the anatomical structures of the lens are generated and organized. The lens is a transparent structure in the eye through which light is focused onto the retina. An example of this process is found in Mus musculus.
|
10 | B0S602 (/IMP) B0S602 (/IMP) B3DGZ1 (/IMP) B3DGZ1 (/IMP) F1RBP8 (/IMP) F1RBP8 (/IMP) O93405 (/IMP) O93405 (/IMP) O93406 (/IMP) O93406 (/IMP) |
Heart morphogenesis GO:0003007
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
10 | B0S602 (/IMP) B0S602 (/IMP) B3DGZ1 (/IMP) B3DGZ1 (/IMP) F1RBP8 (/IMP) F1RBP8 (/IMP) O93405 (/IMP) O93405 (/IMP) O93406 (/IMP) O93406 (/IMP) |
Heart jogging GO:0003146
The morphogenetic process in which the heart cone is displaced to the left with respect to the vector of the anterior-posterior axis.
|
10 | B0S602 (/IMP) B0S602 (/IMP) B3DGZ1 (/IMP) B3DGZ1 (/IMP) F1RBP8 (/IMP) F1RBP8 (/IMP) O93405 (/IMP) O93405 (/IMP) O93406 (/IMP) O93406 (/IMP) |
Cardioblast migration to the midline involved in heart rudiment formation GO:0003319
The orderly movement of a cardioblast toward the midline that contributes to the initial appearance of the heart rudiment.
|
10 | B0S602 (/IGI) B0S602 (/IGI) B3DGZ1 (/IGI) B3DGZ1 (/IGI) F1RBP8 (/IGI) F1RBP8 (/IGI) O93405 (/IGI) O93405 (/IGI) O93406 (/IGI) O93406 (/IGI) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
10 | B0S602 (/IMP) B0S602 (/IMP) B3DGZ1 (/IMP) B3DGZ1 (/IMP) F1RBP8 (/IMP) F1RBP8 (/IMP) O93405 (/IMP) O93405 (/IMP) O93406 (/IMP) O93406 (/IMP) |
Ventricular system development GO:0021591
The process whose specific outcome is the progression of the brain ventricular system over time, from its formation to the mature structure. The brain ventricular system consists of four communicating cavities within the brain that are continuous with the central canal of the spinal cord. These cavities include two lateral ventricles, the third ventricle and the fourth ventricle. Cerebrospinal fluid fills the ventricles and is produced by the choroid plexus.
|
10 | B0S602 (/IMP) B0S602 (/IMP) B3DGZ1 (/IMP) B3DGZ1 (/IMP) F1RBP8 (/IMP) F1RBP8 (/IMP) O93405 (/IMP) O93405 (/IMP) O93406 (/IMP) O93406 (/IMP) |
Adrenal gland development GO:0030325
The process whose specific outcome is the progression of the adrenal gland over time, from its formation to the mature structure. This gland can either be a discrete structure located bilaterally above each kidney, or a cluster of cells in the head kidney that perform the functions of the adrenal gland. In either case, this organ consists of two cells types, aminergic chromaffin cells and steroidogenic cortical cells.
|
10 | B0S602 (/IMP) B0S602 (/IMP) B3DGZ1 (/IMP) B3DGZ1 (/IMP) F1RBP8 (/IMP) F1RBP8 (/IMP) O93405 (/IMP) O93405 (/IMP) O93406 (/IMP) O93406 (/IMP) |
Embryonic heart tube development GO:0035050
The process whose specific outcome is the progression of the embryonic heart tube over time, from its formation to the mature structure. The heart tube forms as the heart rudiment from the heart field.
|
10 | B0S602 (/IGI) B0S602 (/IGI) B3DGZ1 (/IGI) B3DGZ1 (/IGI) F1RBP8 (/IGI) F1RBP8 (/IGI) O93405 (/IGI) O93405 (/IGI) O93406 (/IGI) O93406 (/IGI) |
Embryonic heart tube development GO:0035050
The process whose specific outcome is the progression of the embryonic heart tube over time, from its formation to the mature structure. The heart tube forms as the heart rudiment from the heart field.
|
10 | B0S602 (/IMP) B0S602 (/IMP) B3DGZ1 (/IMP) B3DGZ1 (/IMP) F1RBP8 (/IMP) F1RBP8 (/IMP) O93405 (/IMP) O93405 (/IMP) O93406 (/IMP) O93406 (/IMP) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
10 | F1QC76 (/IMP) F1QC76 (/IMP) F1QC76 (/IMP) F8QXP1 (/IMP) F8QXP1 (/IMP) P11276 (/IMP) P11276 (/IMP) Q7T317 (/IMP) Q7T317 (/IMP) Q7T317 (/IMP) |
Establishment of epithelial cell apical/basal polarity GO:0045198
The specification and formation of the apicobasal polarity of an epithelial cell.
|
10 | B0S602 (/IMP) B0S602 (/IMP) B3DGZ1 (/IMP) B3DGZ1 (/IMP) F1RBP8 (/IMP) F1RBP8 (/IMP) O93405 (/IMP) O93405 (/IMP) O93406 (/IMP) O93406 (/IMP) |
Embryonic viscerocranium morphogenesis GO:0048703
The process in which the anatomical structures of the viscerocranium are generated and organized during the embryonic phase. The viscerocranium is the part of the skull comprising the facial bones.
|
10 | B0S602 (/IGI) B0S602 (/IGI) B3DGZ1 (/IGI) B3DGZ1 (/IGI) F1RBP8 (/IGI) F1RBP8 (/IGI) O93405 (/IGI) O93405 (/IGI) O93406 (/IGI) O93406 (/IGI) |
Endocardial cell differentiation GO:0060956
The process in which a relatively unspecialized cell acquires the specialized structural and/or functional features of an endocardial cell. An endocardial cell is a specialized endothelial cell that makes up the endocardium portion of the heart. The endocardium is the innermost layer of tissue of the heart, and lines the heart chambers.
|
10 | B0S602 (/IMP) B0S602 (/IMP) B3DGZ1 (/IMP) B3DGZ1 (/IMP) F1RBP8 (/IMP) F1RBP8 (/IMP) O93405 (/IMP) O93405 (/IMP) O93406 (/IMP) O93406 (/IMP) |
Lens fiber cell morphogenesis GO:0070309
The process in which the structures of a lens fiber cell are generated and organized. This process occurs while the initially relatively unspecialized cell is acquiring the specialized features of a lens fiber cell. A lens fiber cell is any of the elongated, tightly packed cells that make up the bulk of the mature lens in a camera-type eye.
|
10 | B0S602 (/IMP) B0S602 (/IMP) B3DGZ1 (/IMP) B3DGZ1 (/IMP) F1RBP8 (/IMP) F1RBP8 (/IMP) O93405 (/IMP) O93405 (/IMP) O93406 (/IMP) O93406 (/IMP) |
Cell-cell adhesion GO:0098609
The attachment of one cell to another cell via adhesion molecules.
|
10 | B0S602 (/IMP) B0S602 (/IMP) B3DGZ1 (/IMP) B3DGZ1 (/IMP) F1RBP8 (/IMP) F1RBP8 (/IMP) O93405 (/IMP) O93405 (/IMP) O93406 (/IMP) O93406 (/IMP) |
Cytokine-mediated signaling pathway GO:0019221
A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
9 | P02751 (/TAS) P02751 (/TAS) P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P14780 (/TAS) P14780 (/TAS) P14780 (/TAS) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
9 | P11276 (/ISO) P11276 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Collagen catabolic process GO:0030574
The proteolytic chemical reactions and pathways resulting in the breakdown of collagen in the extracellular matrix, usually carried out by proteases secreted by nearby cells.
|
9 | P33436 (/IDA) P33436 (/IDA) P41245 (/IDA) P41245 (/IDA) P41245 (/IDA) P50282 (/IDA) P50282 (/IDA) P50282 (/IDA) Q9UBG0 (/IDA) |
Positive regulation of granuloma formation GO:0002633
Any process that activates or increases the frequency, rate, or extent of granuloma formation.
|
8 | F1QC76 (/IMP) F1QC76 (/IMP) F1QC76 (/IMP) F8QXP1 (/IMP) F8QXP1 (/IMP) Q7T317 (/IMP) Q7T317 (/IMP) Q7T317 (/IMP) |
Atrioventricular valve morphogenesis GO:0003181
The process in which the structure of the atrioventricular valve is generated and organized.
|
8 | A0A0R4IDI3 (/IMP) A0A0R4IDI3 (/IMP) A2CEW3 (/IMP) A2CEW3 (/IMP) Q58XP5 (/IMP) Q58XP5 (/IMP) Q6JAN2 (/IMP) Q6JAN2 (/IMP) |
Response to bacterium GO:0009617
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium.
|
8 | F1QC76 (/IDA) F1QC76 (/IDA) F1QC76 (/IDA) F8QXP1 (/IDA) F8QXP1 (/IDA) Q7T317 (/IDA) Q7T317 (/IDA) Q7T317 (/IDA) |
Response to bacterium GO:0009617
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium.
|
8 | F1QC76 (/IMP) F1QC76 (/IMP) F1QC76 (/IMP) F8QXP1 (/IMP) F8QXP1 (/IMP) Q7T317 (/IMP) Q7T317 (/IMP) Q7T317 (/IMP) |
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
|
8 | F1QC76 (/IGI) F1QC76 (/IGI) F1QC76 (/IGI) F8QXP1 (/IGI) F8QXP1 (/IGI) Q7T317 (/IGI) Q7T317 (/IGI) Q7T317 (/IGI) |
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
|
8 | F1QC76 (/IMP) F1QC76 (/IMP) F1QC76 (/IMP) F8QXP1 (/IMP) F8QXP1 (/IMP) Q7T317 (/IMP) Q7T317 (/IMP) Q7T317 (/IMP) |
Collagen catabolic process GO:0030574
The proteolytic chemical reactions and pathways resulting in the breakdown of collagen in the extracellular matrix, usually carried out by proteases secreted by nearby cells.
|
8 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) Q64449 (/ISO) |
Fin regeneration GO:0031101
The regrowth of fin tissue following its loss or destruction.
|
8 | F1QC76 (/IMP) F1QC76 (/IMP) F1QC76 (/IMP) F8QXP1 (/IMP) F8QXP1 (/IMP) Q7T317 (/IMP) Q7T317 (/IMP) Q7T317 (/IMP) |
Fin morphogenesis GO:0033334
The process in which the anatomical structures of a fin are generated and organized.
|
8 | F1QC76 (/IMP) F1QC76 (/IMP) F1QC76 (/IMP) F8QXP1 (/IMP) F8QXP1 (/IMP) Q7T317 (/IMP) Q7T317 (/IMP) Q7T317 (/IMP) |
Hematopoietic stem cell migration GO:0035701
The orderly movement of a hematopoietic stem cell from one site to another. A hematopoietic stem cell is a cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system.
|
8 | F1QC76 (/IGI) F1QC76 (/IGI) F1QC76 (/IGI) F8QXP1 (/IGI) F8QXP1 (/IGI) Q7T317 (/IGI) Q7T317 (/IGI) Q7T317 (/IGI) |
Epithelium development GO:0060429
The process whose specific outcome is the progression of an epithelium over time, from its formation to the mature structure. An epithelium is a tissue that covers the internal or external surfaces of an anatomical structure.
|
8 | F1QC76 (/IGI) F1QC76 (/IGI) F1QC76 (/IGI) F8QXP1 (/IGI) F8QXP1 (/IGI) Q7T317 (/IGI) Q7T317 (/IGI) Q7T317 (/IGI) |
Inflammatory response to wounding GO:0090594
The immediate defensive reaction by vertebrate tissue to injury caused by chemical or physical agents.
|
8 | F1QC76 (/IMP) F1QC76 (/IMP) F1QC76 (/IMP) F8QXP1 (/IMP) F8QXP1 (/IMP) Q7T317 (/IMP) Q7T317 (/IMP) Q7T317 (/IMP) |
Proteolysis GO:0006508
The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
|
7 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Response to oxidative stress GO:0006979
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
7 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
7 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Embryo implantation GO:0007566
Attachment of the blastocyst to the uterine lining.
|
7 | P33434 (/IDA) P33434 (/IDA) P33434 (/IDA) P33434 (/IDA) P41245 (/IDA) P41245 (/IDA) P41245 (/IDA) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
7 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Extracellular matrix disassembly GO:0022617
A process that results in the breakdown of the extracellular matrix.
|
7 | P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P14780 (/TAS) P14780 (/TAS) P14780 (/TAS) |
Collagen catabolic process GO:0030574
The proteolytic chemical reactions and pathways resulting in the breakdown of collagen in the extracellular matrix, usually carried out by proteases secreted by nearby cells.
|
7 | P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P14780 (/TAS) P14780 (/TAS) P14780 (/TAS) |
Endodermal cell differentiation GO:0035987
The process in which a relatively unspecialized cell acquires the specialized features of an endoderm cell, a cell of the inner of the three germ layers of the embryo.
|
7 | P08253 (/IEP) P08253 (/IEP) P08253 (/IEP) P08253 (/IEP) P14780 (/IEP) P14780 (/IEP) P14780 (/IEP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
7 | P04937 (/IEP) P04937 (/IEP) P33436 (/IEP) P33436 (/IEP) P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
7 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Ephrin receptor signaling pathway GO:0048013
The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin.
|
7 | P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P14780 (/TAS) P14780 (/TAS) P14780 (/TAS) |
Tissue remodeling GO:0048771
The reorganization or renovation of existing tissues. This process can either change the characteristics of a tissue such as in blood vessel remodeling, or result in the dynamic equilibrium of a tissue such as in bone remodeling.
|
7 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Response to amyloid-beta GO:1904645
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a amyloid-beta stimulus.
|
7 | P33434 (/IDA) P33434 (/IDA) P33434 (/IDA) P33434 (/IDA) P41245 (/IDA) P41245 (/IDA) P41245 (/IDA) |
Response to amyloid-beta GO:1904645
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a amyloid-beta stimulus.
|
7 | P08253 (/ISS) P08253 (/ISS) P08253 (/ISS) P08253 (/ISS) P14780 (/ISS) P14780 (/ISS) P14780 (/ISS) |
Positive regulation of vascular smooth muscle cell proliferation GO:1904707
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
7 | P08253 (/IMP) P08253 (/IMP) P08253 (/IMP) P08253 (/IMP) P14780 (/IMP) P14780 (/IMP) P14780 (/IMP) |
Positive regulation of vascular smooth muscle cell proliferation GO:1904707
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
7 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
6 | P33434 (/IDA) P33434 (/IDA) P33434 (/IDA) P33434 (/IDA) P33436 (/IDA) P33436 (/IDA) |
Cellular protein metabolic process GO:0044267
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
|
6 | P02751 (/TAS) P02751 (/TAS) P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) |
Response to oxidative stress GO:0006979
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
5 | P33436 (/IDA) P33436 (/IDA) P50282 (/IDA) P50282 (/IDA) P50282 (/IDA) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
5 | P33436 (/IDA) P33436 (/IDA) P50282 (/IDA) P50282 (/IDA) P50282 (/IDA) |
Parturition GO:0007567
The reproductive process in which the parent is separated from its offspring either by giving birth to live young or by laying eggs.
|
5 | P33436 (/IEP) P33436 (/IEP) P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
5 | P33436 (/IDA) P33436 (/IDA) P50282 (/IDA) P50282 (/IDA) P50282 (/IDA) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
5 | P33436 (/IEP) P33436 (/IEP) P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Response to radiation GO:0009314
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation.
|
5 | P33436 (/IEP) P33436 (/IEP) P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Extracellular matrix organization GO:0030198
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
|
5 | P04937 (/IMP) P04937 (/IMP) P41245 (/IMP) P41245 (/IMP) P41245 (/IMP) |
Response to retinoic acid GO:0032526
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus.
|
5 | P33436 (/IEP) P33436 (/IEP) P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Response to nicotine GO:0035094
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus.
|
5 | P33436 (/IEP) P33436 (/IEP) P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
ERAD pathway GO:0036503
The protein catabolic pathway which targets endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. It begins with recognition of the ER-resident protein, includes retrotranslocation (dislocation) of the protein from the ER to the cytosol, protein modifications necessary for correct substrate transfer (e.g. ubiquitination), transport of the protein to the proteasome, and ends with degradation of the protein by the cytoplasmic proteasome.
|
5 | Q80Z70 (/ISS) Q9ESM7 (/ISS) Q9ESM7 (/ISS) Q9UBV2 (/ISS) Q9Z2G6 (/ISS) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
5 | P33436 (/IDA) P33436 (/IDA) P50282 (/IDA) P50282 (/IDA) P50282 (/IDA) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
5 | P04937 (/IMP) P04937 (/IMP) P14780 (/IMP) P14780 (/IMP) P14780 (/IMP) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
5 | P11276 (/ISO) P11276 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Tissue remodeling GO:0048771
The reorganization or renovation of existing tissues. This process can either change the characteristics of a tissue such as in blood vessel remodeling, or result in the dynamic equilibrium of a tissue such as in bone remodeling.
|
5 | P33436 (/IDA) P33436 (/IDA) P50282 (/IDA) P50282 (/IDA) P50282 (/IDA) |
Response to hyperoxia GO:0055093
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating increased oxygen tension.
|
5 | P33436 (/IEP) P33436 (/IEP) P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
5 | P04937 (/IEP) P04937 (/IEP) P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Cellular response to cytokine stimulus GO:0071345
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
|
5 | P33436 (/IEP) P33436 (/IEP) P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Cellular response to interleukin-1 GO:0071347
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
|
5 | P33436 (/IEP) P33436 (/IEP) P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
4 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
4 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) |
Lymph vessel development GO:0001945
The process whose specific outcome is the progression of a lymph vessel over time, from its formation to the mature structure.
|
4 | Q6DG10 (/IMP) Q6DG10 (/IMP) Q7SZM5 (/IMP) Q7SZM5 (/IMP) |
Blood vessel maturation GO:0001955
A developmental process, independent of morphogenetic (shape) change, that is required for a blood vessel to attain its fully functional state.
|
4 | P33434 (/IGI) P33434 (/IGI) P33434 (/IGI) P33434 (/IGI) |
Intramembranous ossification GO:0001957
Direct ossification that occurs within mesenchyme or an accumulation of relatively unspecialized cells.
|
4 | P33434 (/IGI) P33434 (/IGI) P33434 (/IGI) P33434 (/IGI) |
Proteolysis GO:0006508
The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
|
4 | P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) |
Triglyceride metabolic process GO:0006641
The chemical reactions and pathways involving triglyceride, any triester of glycerol. The three fatty acid residues may all be the same or differ in any permutation. Triglycerides are important components of plant oils, animal fats and animal plasma lipoproteins.
|
4 | Q80Z70 (/ISS) Q9ESM7 (/ISS) Q9ESM7 (/ISS) Q9UBV2 (/ISS) |
Cell adhesion GO:0007155
The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
|
4 | F1NJT3 (/IDA) F1NJT3 (/IDA) P11276 (/IDA) P11276 (/IDA) |
Negative regulation of cell adhesion GO:0007162
Any process that stops, prevents, or reduces the frequency, rate or extent of cell adhesion.
|
4 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) |
Protein secretion GO:0009306
The controlled release of proteins from a cell.
|
4 | Q80Z70 (/ISS) Q9ESM7 (/ISS) Q9ESM7 (/ISS) Q9UBV2 (/ISS) |
Response to mechanical stimulus GO:0009612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
4 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) |
Peripheral nervous system axon regeneration GO:0014012
The regrowth of axons outside the central nervous system (outside the brain and spinal cord) following an axonal injury.
|
4 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) |
Response to activity GO:0014823
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an activity stimulus.
|
4 | P04937 (/IEP) P04937 (/IEP) P33436 (/IEP) P33436 (/IEP) |
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
|
4 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
4 | P04937 (/IMP) P04937 (/IMP) P33436 (/IMP) P33436 (/IMP) |
Collagen catabolic process GO:0030574
The proteolytic chemical reactions and pathways resulting in the breakdown of collagen in the extracellular matrix, usually carried out by proteases secreted by nearby cells.
|
4 | P33434 (/IMP) P33434 (/IMP) P33434 (/IMP) P33434 (/IMP) |
Retinal ganglion cell axon guidance GO:0031290
The process in which the migration of an axon growth cone of a retinal ganglion cell (RGC) is directed to its target in the brain in response to a combination of attractive and repulsive cues.
|
4 | Q6DG10 (/IGI) Q6DG10 (/IGI) Q7SZM5 (/IGI) Q7SZM5 (/IGI) |
Cellular response to reactive oxygen species GO:0034614
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.
|
4 | P33434 (/IMP) P33434 (/IMP) P33434 (/IMP) P33434 (/IMP) |
Response to hydrogen peroxide GO:0042542
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
4 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
4 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) |
Response to estrogen GO:0043627
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
|
4 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) |
Negative regulation of vasoconstriction GO:0045906
Any process that stops, prevents, or reduces the frequency, rate or extent of vasoconstriction.
|
4 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
4 | P33434 (/IMP) P33434 (/IMP) P33434 (/IMP) P33434 (/IMP) |
Skeletal system morphogenesis GO:0048705
The process in which the anatomical structures of the skeleton are generated and organized.
|
4 | P33434 (/IGI) P33434 (/IGI) P33434 (/IGI) P33434 (/IGI) |
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
|
4 | P33434 (/IGI) P33434 (/IGI) P33434 (/IGI) P33434 (/IGI) |
Bone trabecula formation GO:0060346
The process of creating a trabecula in the bone. A trabecula is a tissue element in the form of a small beam, strut or rod.
|
4 | P33434 (/IGI) P33434 (/IGI) P33434 (/IGI) P33434 (/IGI) |
Prostate gland epithelium morphogenesis GO:0060740
The process in which the anatomical structures of epithelia of the prostate gland are generated and organized. An epithelium consists of closely packed cells arranged in one or more layers, that covers the outer surfaces of the body or lines any internal cavity or tube.
|
4 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) |
Cellular response to amino acid stimulus GO:0071230
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups.
|
4 | P33434 (/IDA) P33434 (/IDA) P33434 (/IDA) P33434 (/IDA) |
Cellular response to estradiol stimulus GO:0071392
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
4 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
3 | P41245 (/IGI) P41245 (/IGI) P41245 (/IGI) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
3 | P41245 (/IMP) P41245 (/IMP) P41245 (/IMP) |
Ossification GO:0001503
The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
3 | P14780 (/IMP) P14780 (/IMP) P14780 (/IMP) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Positive regulation of leukocyte migration GO:0002687
Any process that activates or increases the frequency, rate, or extent of leukocyte migration.
|
3 | P50282 (/IDA) P50282 (/IDA) P50282 (/IDA) |
Positive regulation of leukocyte migration GO:0002687
Any process that activates or increases the frequency, rate, or extent of leukocyte migration.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Proteolysis GO:0006508
The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
|
3 | Q61830 (/ISO) Q61830 (/ISO) Q62028 (/ISO) |
Response to nutrient GO:0007584
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Response to heat GO:0009408
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Response to mechanical stimulus GO:0009612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Response to high light intensity GO:0009644
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a high light intensity stimulus.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Response to organic substance GO:0010033
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Response to organic cyclic compound GO:0014070
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Transformation of host cell by virus GO:0019087
Any virus-induced change in the morphological, biochemical, or growth parameters of a cell.
|
3 | P50282 (/IDA) P50282 (/IDA) P50282 (/IDA) |
Transformation of host cell by virus GO:0019087
Any virus-induced change in the morphological, biochemical, or growth parameters of a cell.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Extracellular matrix organization GO:0030198
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
|
3 | P41245 (/IGI) P41245 (/IGI) P41245 (/IGI) |
Macrophage differentiation GO:0030225
The process in which a relatively unspecialized monocyte acquires the specialized features of a macrophage.
|
3 | P14780 (/TAS) P14780 (/TAS) P14780 (/TAS) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
3 | P14780 (/IGI) P14780 (/IGI) P14780 (/IGI) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
3 | P14780 (/TAS) P14780 (/TAS) P14780 (/TAS) |
Positive regulation of synaptic plasticity GO:0031915
A process that increases synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
|
3 | P50282 (/IMP) P50282 (/IMP) P50282 (/IMP) |
Positive regulation of synaptic plasticity GO:0031915
A process that increases synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Response to vitamin A GO:0033189
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin A stimulus.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Response to tumor necrosis factor GO:0034612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Cellular response to reactive oxygen species GO:0034614
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.
|
3 | P14780 (/IDA) P14780 (/IDA) P14780 (/IDA) |
Cellular response to reactive oxygen species GO:0034614
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
3 | P41245 (/IMP) P41245 (/IMP) P41245 (/IMP) |
Neutrophil degranulation GO:0043312
The regulated exocytosis of secretory granules containing preformed mediators such as proteases, lipases, and inflammatory mediators by a neutrophil.
|
3 | P14780 (/TAS) P14780 (/TAS) P14780 (/TAS) |
Positive regulation of DNA binding GO:0043388
Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
|
3 | P14780 (/IDA) P14780 (/IDA) P14780 (/IDA) |
Positive regulation of DNA binding GO:0043388
Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Response to ethanol GO:0045471
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Positive regulation of epidermal growth factor receptor signaling pathway GO:0045742
Any process that activates or increases the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity.
|
3 | P14780 (/IMP) P14780 (/IMP) P14780 (/IMP) |
Positive regulation of epidermal growth factor receptor signaling pathway GO:0045742
Any process that activates or increases the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
|
3 | P50282 (/IMP) P50282 (/IMP) P50282 (/IMP) |
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Negative regulation of fibroblast proliferation GO:0048147
Any process that stops, prevents, or reduces the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
3 | P50282 (/IMP) P50282 (/IMP) P50282 (/IMP) |
Negative regulation of fibroblast proliferation GO:0048147
Any process that stops, prevents, or reduces the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Protein complex oligomerization GO:0051259
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers; protein oligomers may be composed of different or identical monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
3 | P50282 (/IDA) P50282 (/IDA) P50282 (/IDA) |
Protein complex oligomerization GO:0051259
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers; protein oligomers may be composed of different or identical monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Positive regulation of keratinocyte migration GO:0051549
Any process that activates or increases the frequency, rate or extent of keratinocyte migration.
|
3 | P14780 (/IMP) P14780 (/IMP) P14780 (/IMP) |
Positive regulation of keratinocyte migration GO:0051549
Any process that activates or increases the frequency, rate or extent of keratinocyte migration.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Cellular response to cadmium ion GO:0071276
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
|
3 | P14780 (/IDA) P14780 (/IDA) P14780 (/IDA) |
Cellular response to cadmium ion GO:0071276
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Cellular response to iron(III) ion GO:0071283
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron(III) ion stimulus.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Cellular response to tumor necrosis factor GO:0071356
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Cellular response to low-density lipoprotein particle stimulus GO:0071404
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a low-density lipoprotein particle stimulus.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Cellular response to cell-matrix adhesion GO:0071460
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of cell-matrix adhesion.
|
3 | P50282 (/IEP) P50282 (/IEP) P50282 (/IEP) |
Cellular response to cell-matrix adhesion GO:0071460
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of cell-matrix adhesion.
|
3 | P50282 (/IMP) P50282 (/IMP) P50282 (/IMP) |
Cellular response to cell-matrix adhesion GO:0071460
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of cell-matrix adhesion.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Positive regulation of release of cytochrome c from mitochondria GO:0090200
Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
|
3 | P14780 (/IMP) P14780 (/IMP) P14780 (/IMP) |
Positive regulation of release of cytochrome c from mitochondria GO:0090200
Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Regulation of neuroinflammatory response GO:0150077
Any process that modulates the frequency, rate or extent of neuroinflammatory response.
|
3 | P14780 (/TAS) P14780 (/TAS) P14780 (/TAS) |
Positive regulation of receptor binding GO:1900122
Any process that activates or increases the frequency, rate or extent of a protein or other molecule binding to a receptor.
|
3 | P14780 (/IDA) P14780 (/IDA) P14780 (/IDA) |
Positive regulation of receptor binding GO:1900122
Any process that activates or increases the frequency, rate or extent of a protein or other molecule binding to a receptor.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Negative regulation of epithelial cell differentiation involved in kidney development GO:2000697
Any process that stops, prevents or reduces the frequency, rate or extent of epithelial cell differentiation involved in kidney development.
|
3 | P41245 (/IDA) P41245 (/IDA) P41245 (/IDA) |
Negative regulation of epithelial cell differentiation involved in kidney development GO:2000697
Any process that stops, prevents or reduces the frequency, rate or extent of epithelial cell differentiation involved in kidney development.
|
3 | P14780 (/ISS) P14780 (/ISS) P14780 (/ISS) |
Negative regulation of intrinsic apoptotic signaling pathway GO:2001243
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway.
|
3 | P14780 (/IMP) P14780 (/IMP) P14780 (/IMP) |
Negative regulation of intrinsic apoptotic signaling pathway GO:2001243
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Negative regulation of cation channel activity GO:2001258
Any process that stops, prevents or reduces the frequency, rate or extent of cation channel activity.
|
3 | P14780 (/IDA) P14780 (/IDA) P14780 (/IDA) |
Negative regulation of cation channel activity GO:2001258
Any process that stops, prevents or reduces the frequency, rate or extent of cation channel activity.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway GO:2001268
Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
|
3 | P14780 (/IMP) P14780 (/IMP) P14780 (/IMP) |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway GO:2001268
Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Ossification GO:0001503
The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
|
2 | P04937 (/TAS) P04937 (/TAS) |
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
|
2 | P33436 (/IEP) P33436 (/IEP) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
2 | P33436 (/IDA) P33436 (/IDA) |
Ovulation from ovarian follicle GO:0001542
The process leading to the rupture of the follicle, releasing the centrally located oocyte into the oviduct. An example of this is found in Mus musculus.
|
2 | P33436 (/IEP) P33436 (/IEP) |
Luteinization GO:0001553
The set of processes resulting in differentiation of theca and granulosa cells into luteal cells and in the formation of a corpus luteum after ovulation.
|
2 | P33436 (/IEP) P33436 (/IEP) |
Cell activation GO:0001775
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
2 | P04937 (/IMP) P04937 (/IMP) |
Cell activation GO:0001775
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Regulation of protein phosphorylation GO:0001932
Any process that modulates the frequency, rate or extent of addition of phosphate groups into an amino acid in a protein.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Regulation of protein phosphorylation GO:0001932
Any process that modulates the frequency, rate or extent of addition of phosphate groups into an amino acid in a protein.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
|
2 | Q90611 (/IMP) Q90611 (/IMP) |
Platelet degranulation GO:0002576
The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
|
2 | P02751 (/TAS) P02751 (/TAS) |
Response to ischemia GO:0002931
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a inadequate blood supply.
|
2 | P04937 (/IEP) P04937 (/IEP) |
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
|
2 | P22897 (/IDA) Q62028 (/IDA) |
Substrate-dependent cell migration GO:0006929
The orderly movement of a cell from one site to another along a substrate such as the extracellular matrix; the migrating cell forms a protrusion that attaches to the substrate.
|
2 | F1NJT3 (/IMP) F1NJT3 (/IMP) |
Cell-substrate junction assembly GO:0007044
The aggregation, arrangement and bonding together of a set of components to form a junction between a cell and its substrate.
|
2 | P11276 (/IDA) P11276 (/IDA) |
Cell adhesion GO:0007155
The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
|
2 | P02751 (/NAS) P02751 (/NAS) |
Cell-matrix adhesion GO:0007160
The binding of a cell to the extracellular matrix via adhesion molecules.
|
2 | P11276 (/IDA) P11276 (/IDA) |
Cell-matrix adhesion GO:0007160
The binding of a cell to the extracellular matrix via adhesion molecules.
|
2 | P04937 (/IMP) P04937 (/IMP) |
Cell-matrix adhesion GO:0007160
The binding of a cell to the extracellular matrix via adhesion molecules.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Calcium-independent cell-matrix adhesion GO:0007161
The binding of a cell to the extracellular matrix via adhesion molecules that do not require the presence of calcium for the interaction.
|
2 | P11276 (/IDA) P11276 (/IDA) |
Negative regulation of cell adhesion GO:0007162
Any process that stops, prevents, or reduces the frequency, rate or extent of cell adhesion.
|
2 | P33436 (/IDA) P33436 (/IDA) |
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
|
2 | P33436 (/IEP) P33436 (/IEP) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
2 | F1NJT3 (/IDA) F1NJT3 (/IDA) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Glial cell migration GO:0008347
The orderly movement of a glial cell, non-neuronal cells that provide support and nutrition, maintain homeostasis, form myelin, and participate in signal transmission in the nervous system.
|
2 | P04937 (/IDA) P04937 (/IDA) |
Glial cell migration GO:0008347
The orderly movement of a glial cell, non-neuronal cells that provide support and nutrition, maintain homeostasis, form myelin, and participate in signal transmission in the nervous system.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Response to wounding GO:0009611
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
|
2 | P04937 (/IEP) P04937 (/IEP) |
Response to wounding GO:0009611
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
|
2 | P02751 (/NAS) P02751 (/NAS) |
Response to mechanical stimulus GO:0009612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
2 | P33436 (/IDA) P33436 (/IDA) |
Response to iron ion GO:0010039
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus.
|
2 | P04937 (/IEP) P04937 (/IEP) |
Response to ozone GO:0010193
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ozone stimulus.
|
2 | P04937 (/IEP) P04937 (/IEP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Peripheral nervous system axon regeneration GO:0014012
The regrowth of axons outside the central nervous system (outside the brain and spinal cord) following an axonal injury.
|
2 | P33436 (/IDA) P33436 (/IDA) |
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
|
2 | P33436 (/IMP) P33436 (/IMP) |
Peptide cross-linking GO:0018149
The formation of a covalent cross-link between or within protein chains.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Peptide cross-linking GO:0018149
The formation of a covalent cross-link between or within protein chains.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Extracellular matrix organization GO:0030198
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Extracellular matrix organization GO:0030198
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
|
2 | P02751 (/TAS) P02751 (/TAS) |
Cell-substrate adhesion GO:0031589
The attachment of a cell to the underlying substrate via adhesion molecules.
|
2 | F1NJT3 (/IMP) F1NJT3 (/IMP) |
Integrin activation GO:0033622
The aggregation, arrangement and bonding together of an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits, that lead to the increased affinity of the integrin for its extracellular ligands.
|
2 | P02751 (/IMP) P02751 (/IMP) |
Integrin activation GO:0033622
The aggregation, arrangement and bonding together of an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits, that lead to the increased affinity of the integrin for its extracellular ligands.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Response to cytokine GO:0034097
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
|
2 | P33436 (/IEP) P33436 (/IEP) |
Substrate adhesion-dependent cell spreading GO:0034446
The morphogenetic process that results in flattening of a cell as a consequence of its adhesion to a substrate.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Substrate adhesion-dependent cell spreading GO:0034446
The morphogenetic process that results in flattening of a cell as a consequence of its adhesion to a substrate.
|
2 | P02751 (/IMP) P02751 (/IMP) |
Substrate adhesion-dependent cell spreading GO:0034446
The morphogenetic process that results in flattening of a cell as a consequence of its adhesion to a substrate.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Cellular response to vascular endothelial growth factor stimulus GO:0035924
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
|
2 | P04937 (/IEP) P04937 (/IEP) |
Endodermal cell differentiation GO:0035987
The process in which a relatively unspecialized cell acquires the specialized features of an endoderm cell, a cell of the inner of the three germ layers of the embryo.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Endodermal cell differentiation GO:0035987
The process in which a relatively unspecialized cell acquires the specialized features of an endoderm cell, a cell of the inner of the three germ layers of the embryo.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Cellular response to platelet-derived growth factor stimulus GO:0036120
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a platelet-derived growth factor stimulus.
|
2 | P04937 (/IEP) P04937 (/IEP) |
ERAD pathway GO:0036503
The protein catabolic pathway which targets endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. It begins with recognition of the ER-resident protein, includes retrotranslocation (dislocation) of the protein from the ER to the cytosol, protein modifications necessary for correct substrate transfer (e.g. ubiquitination), transport of the protein to the proteasome, and ends with degradation of the protein by the cytoplasmic proteasome.
|
2 | Q9UBV2 (/IMP) Q9Z2G6 (/IMP) |
Response to hydrogen peroxide GO:0042542
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
2 | P33436 (/IDA) P33436 (/IDA) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | P33436 (/IDA) P33436 (/IDA) |
Regulation of MAPK cascade GO:0043408
Any process that modulates the frequency, rate or extent of signal transduction mediated by the MAP kinase (MAPK) cascade.
|
2 | Q90611 (/IMP) Q90611 (/IMP) |
Response to estrogen GO:0043627
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
|
2 | P33436 (/IDA) P33436 (/IDA) |
Post-translational protein modification GO:0043687
The process of covalently altering one or more amino acids in a protein after the protein has been completely translated and released from the ribosome.
|
2 | P02751 (/TAS) P02751 (/TAS) |
Apical protein localization GO:0045176
Any process in which a protein is transported to, or maintained in, apical regions of the cell.
|
2 | F1NJT3 (/IDA) F1NJT3 (/IDA) |
Positive regulation of axon extension GO:0045773
Any process that activates or increases the frequency, rate or extent of axon extension.
|
2 | P11276 (/IDA) P11276 (/IDA) |
Negative regulation of vasoconstriction GO:0045906
Any process that stops, prevents, or reduces the frequency, rate or extent of vasoconstriction.
|
2 | P33436 (/IDA) P33436 (/IDA) |
Focal adhesion assembly GO:0048041
The aggregation and bonding together of a set of components to form a focal adhesion, a complex of intracellular signaling and structural proteins that provides a structural link between the internal actin cytoskeleton and the ECM, and also function as a locus of signal transduction activity.
|
2 | F1NJT3 (/IDA) F1NJT3 (/IDA) |
Positive regulation of fibroblast proliferation GO:0048146
Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Positive regulation of fibroblast proliferation GO:0048146
Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Leukocyte migration GO:0050900
The movement of a leukocyte within or between different tissues and organs of the body.
|
2 | P02751 (/TAS) P02751 (/TAS) |
Positive regulation of chemotaxis GO:0050921
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
|
2 | P04937 (/IDA) P04937 (/IDA) |
Positive regulation of chemotaxis GO:0050921
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Response to glucocorticoid GO:0051384
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
|
2 | P04937 (/IEP) P04937 (/IEP) |
Response to electrical stimulus GO:0051602
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electrical stimulus.
|
2 | P33436 (/IEP) P33436 (/IEP) |
Interaction with symbiont GO:0051702
An interaction between two organisms living together in more or less intimate association. The term symbiont is used for the smaller (macro) of the two members of a symbiosis; the various forms of symbiosis include parasitism, commensalism and mutualism.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Interaction with symbiont GO:0051702
An interaction between two organisms living together in more or less intimate association. The term symbiont is used for the smaller (macro) of the two members of a symbiosis; the various forms of symbiosis include parasitism, commensalism and mutualism.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Negative regulation of focal adhesion assembly GO:0051895
Any process that stops, prevents, or reduces the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions.
|
2 | Q90611 (/IDA) Q90611 (/IDA) |
Negative regulation of focal adhesion assembly GO:0051895
Any process that stops, prevents, or reduces the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions.
|
2 | Q90611 (/IMP) Q90611 (/IMP) |
Interaction with other organism via secreted substance involved in symbiotic interaction GO:0052047
An interaction with a second organism mediated by a substance secreted by the first organism, where the two organisms are in a symbiotic interaction.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Interaction with other organism via secreted substance involved in symbiotic interaction GO:0052047
An interaction with a second organism mediated by a substance secreted by the first organism, where the two organisms are in a symbiotic interaction.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Prostate gland epithelium morphogenesis GO:0060740
The process in which the anatomical structures of epithelia of the prostate gland are generated and organized. An epithelium consists of closely packed cells arranged in one or more layers, that covers the outer surfaces of the body or lines any internal cavity or tube.
|
2 | P33436 (/IMP) P33436 (/IMP) |
Cell migration involved in heart formation GO:0060974
The orderly movement of a cell from one site to another that contribute to the formation of the heart. The initial heart structure is made up of mesoderm-derived heart progenitor cells and neural crest-derived cells.
|
2 | F1NJT3 (/IMP) F1NJT3 (/IMP) |
Negative regulation of cartilage development GO:0061037
Any process that decreases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
2 | Q90611 (/IMP) Q90611 (/IMP) |
Regulation of ERK1 and ERK2 cascade GO:0070372
Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Regulation of ERK1 and ERK2 cascade GO:0070372
Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
2 | Q61830 (/IDA) Q61830 (/IDA) |
Cellular response to mercury ion GO:0071288
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mercury ion stimulus.
|
2 | P04937 (/IDA) P04937 (/IDA) |
Cellular response to mercury ion GO:0071288
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mercury ion stimulus.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Cellular response to glucose stimulus GO:0071333
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
2 | P04937 (/IEP) P04937 (/IEP) |
Cellular response to interferon-gamma GO:0071346
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far.
|
2 | Q61830 (/IDA) Q61830 (/IDA) |
Cellular response to interleukin-1 GO:0071347
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
|
2 | P04937 (/IMP) P04937 (/IMP) |
Cellular response to interleukin-1 GO:0071347
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Cellular response to interleukin-4 GO:0071353
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-4 stimulus.
|
2 | Q61830 (/IDA) Q61830 (/IDA) |
Cellular response to prostaglandin E stimulus GO:0071380
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus.
|
2 | P04937 (/IEP) P04937 (/IEP) |
Cellular response to estradiol stimulus GO:0071392
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
2 | P33436 (/IMP) P33436 (/IMP) |
Cellular response to fluid shear stress GO:0071498
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface.
|
2 | P33436 (/IEP) P33436 (/IEP) |
Cellular response to transforming growth factor beta stimulus GO:0071560
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
2 | P04937 (/IEP) P04937 (/IEP) |
Cellular response to BMP stimulus GO:0071773
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
|
2 | P04937 (/IEP) P04937 (/IEP) |
Axis elongation involved in somitogenesis GO:0090245
The developmental growth that results in the elongation of the rostral-caudal axis that contributes to somitogenesis.
|
2 | F1NJT3 (/IDA) F1NJT3 (/IDA) |
Neural crest cell migration involved in autonomic nervous system development GO:1901166
Any neural crest cell migration that is involved in autonomic nervous system development.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Neural crest cell migration involved in autonomic nervous system development GO:1901166
Any neural crest cell migration that is involved in autonomic nervous system development.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Positive regulation of substrate-dependent cell migration, cell attachment to substrate GO:1904237
Any process that activates or increases the frequency, rate or extent of substrate-dependent cell migration, cell attachment to substrate.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Positive regulation of substrate-dependent cell migration, cell attachment to substrate GO:1904237
Any process that activates or increases the frequency, rate or extent of substrate-dependent cell migration, cell attachment to substrate.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Cellular response to angiotensin GO:1904385
\Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an angiotensin stimulus. Angiotensin is any of three physiologically active peptides (angiotensin II, III, or IV) processed from angiotensinogen.\
|
2 | P04937 (/IEP) P04937 (/IEP) |
Cellular response to amyloid-beta GO:1904646
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a amyloid-beta stimulus.
|
2 | P04937 (/IEP) P04937 (/IEP) |
Negative regulation of cartilage condensation GO:1904932
Any process that stops, prevents or reduces the frequency, rate or extent of cartilage condensation.
|
2 | Q90611 (/IMP) Q90611 (/IMP) |
Cellular response to insulin-like growth factor stimulus GO:1990314
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin-like growth factor stimulus.
|
2 | Q90611 (/IMP) Q90611 (/IMP) |
Negative regulation of transforming growth factor-beta secretion GO:2001202
Any process that stops, prevents or reduces the frequency, rate or extent of transforming growth factor-beta secretion.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Negative regulation of transforming growth factor-beta secretion GO:2001202
Any process that stops, prevents or reduces the frequency, rate or extent of transforming growth factor-beta secretion.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Osteoblast differentiation GO:0001649
The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
|
1 | Q9UBG0 (/HDA) |
Cytokine production GO:0001816
The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
1 | Q13018 (/IMP) |
Cytokine production GO:0001816
The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
1 | Q62028 (/ISO) |
Triglyceride metabolic process GO:0006641
The chemical reactions and pathways involving triglyceride, any triester of glycerol. The three fatty acid residues may all be the same or differ in any permutation. Triglycerides are important components of plant oils, animal fats and animal plasma lipoproteins.
|
1 | Q9Z2G6 (/IMP) |
Protein secretion GO:0009306
The controlled release of proteins from a cell.
|
1 | Q9Z2G6 (/IMP) |
Ubiquitin-dependent ERAD pathway GO:0030433
The series of steps necessary to target endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. Begins with recognition of the ER-resident protein, includes retrotranslocation (dislocation) of the protein from the ER to the cytosol, protein ubiquitination necessary for correct substrate transfer, transport of the protein to the proteasome, and ends with degradation of the protein by the cytoplasmic proteasome.
|
1 | Q9UBV2 (/TAS) |
Retrograde protein transport, ER to cytosol GO:0030970
The directed movement of unfolded or misfolded proteins from the endoplasmic reticulum to the cytosol through the translocon.
|
1 | Q9UBV2 (/IMP) |
Retrograde protein transport, ER to cytosol GO:0030970
The directed movement of unfolded or misfolded proteins from the endoplasmic reticulum to the cytosol through the translocon.
|
1 | Q9Z2G6 (/ISO) |
Response to endoplasmic reticulum stress GO:0034976
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
|
1 | Q9Z2G6 (/IMP) |
ERAD pathway GO:0036503
The protein catabolic pathway which targets endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. It begins with recognition of the ER-resident protein, includes retrotranslocation (dislocation) of the protein from the ER to the cytosol, protein modifications necessary for correct substrate transfer (e.g. ubiquitination), transport of the protein to the proteasome, and ends with degradation of the protein by the cytoplasmic proteasome.
|
1 | Q9Z2G6 (/ISO) |
Positive regulation of DNA damage response, signal transduction by p53 class mediator GO:0043517
Any process that activates, maintains or increases the rate of the cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage.
|
1 | Q13018 (/IMP) |
Positive regulation of DNA damage response, signal transduction by p53 class mediator GO:0043517
Any process that activates, maintains or increases the rate of the cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage.
|
1 | Q62028 (/ISO) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
1 | Q9UBV2 (/TAS) |
Transmembrane transport GO:0055085
The process in which a solute is transported across a lipid bilayer, from one side of a membrane to the other.
|
1 | Q9UBV2 (/TAS) |
Reactive oxygen species metabolic process GO:0072593
The chemical reactions and pathways involving a reactive oxygen species, any molecules or ions formed by the incomplete one-electron reduction of oxygen. They contribute to the microbicidal activity of phagocytes, regulation of signal transduction and gene expression, and the oxidative damage to biopolymers.
|
1 | Q13018 (/IDA) |
Reactive oxygen species metabolic process GO:0072593
The chemical reactions and pathways involving a reactive oxygen species, any molecules or ions formed by the incomplete one-electron reduction of oxygen. They contribute to the microbicidal activity of phagocytes, regulation of signal transduction and gene expression, and the oxidative damage to biopolymers.
|
1 | Q62028 (/ISO) |
Positive regulation of arachidonic acid secretion GO:0090238
Any process that increases the rate, frequency, or extent of arachidonic acid secretion, the controlled release of arachidonic acid from a cell or a tissue.
|
1 | Q62028 (/IDA) |
Replicative senescence GO:0090399
A cell aging process associated with the dismantling of a cell as a response to telomere shortening and/or cellular aging.
|
1 | Q13018 (/IMP) |
Replicative senescence GO:0090399
A cell aging process associated with the dismantling of a cell as a response to telomere shortening and/or cellular aging.
|
1 | Q62028 (/ISO) |
Oxidative stress-induced premature senescence GO:0090403
A cellular senescence process associated with the dismantling of a cell as a response to oxidative stress, e.g. high levels of reactive oxygen species, such as superoxide anions, hydrogen peroxide, and hydroxyl radicals.
|
1 | Q13018 (/IMP) |
Oxidative stress-induced premature senescence GO:0090403
A cellular senescence process associated with the dismantling of a cell as a response to oxidative stress, e.g. high levels of reactive oxygen species, such as superoxide anions, hydrogen peroxide, and hydroxyl radicals.
|
1 | Q62028 (/ISO) |
Negative regulation of phospholipase A2 activity GO:1900138
Any process that stops, prevents or reduces the frequency, rate or extent of phospholipase A2 activity.
|
1 | Q13018 (/ISS) |
Negative regulation of arachidonic acid secretion GO:1900139
Any process that stops, prevents or reduces the frequency, rate or extent of arachidonic acid secretion.
|
1 | Q13018 (/ISS) |
Endoplasmic reticulum mannose trimming GO:1904380
Any protein alpha-1,2-demannosylation that takes place in the endoplasmic reticulum quality control compartment (ERQC).
|
1 | Q9UBV2 (/TAS) |
There are 65 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
22 |
F1NJT3 (/IDA)
F1NJT3 (/IDA)
P02751 (/IDA)
P02751 (/IDA)
P04937 (/IDA)
P04937 (/IDA)
P07589 (/IDA)
P07589 (/IDA)
P08253 (/IDA)
P08253 (/IDA)
(12 more) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
16 |
P02751 (/HDA)
P02751 (/HDA)
P08253 (/HDA)
P08253 (/HDA)
P08253 (/HDA)
P08253 (/HDA)
P11276 (/HDA)
P11276 (/HDA)
P14780 (/HDA)
P14780 (/HDA)
(6 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
15 |
O18733 (/ISS)
O18733 (/ISS)
O18733 (/ISS)
P41245 (/ISS)
P41245 (/ISS)
P41245 (/ISS)
P41246 (/ISS)
P41246 (/ISS)
P41246 (/ISS)
P50282 (/ISS)
(5 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
13 |
F1M495 (/ISS)
F1PGC5 (/ISS)
F6Y1A5 (/ISS)
F7CUS6 (/ISS)
G1L1S3 (/ISS)
G1PP42 (/ISS)
G1QLJ9 (/ISS)
P49259 (/ISS)
P49260 (/ISS)
Q5R880 (/ISS)
(3 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
12 |
P02751 (/HDA)
P02751 (/HDA)
P08253 (/HDA)
P08253 (/HDA)
P08253 (/HDA)
P08253 (/HDA)
P11276 (/HDA)
P11276 (/HDA)
P33434 (/HDA)
P33434 (/HDA)
(2 more) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
11 |
P02751 (/TAS)
P02751 (/TAS)
P07589 (/TAS)
P07589 (/TAS)
P08253 (/TAS)
P08253 (/TAS)
P08253 (/TAS)
P08253 (/TAS)
P14780 (/TAS)
P14780 (/TAS)
(1 more) |
Interstitial matrix GO:0005614
A type of extracellular matrix found in interstitial connective tissue, characterized by the presence of fibronectins, proteoglycans, and types I, III, V, VI, VII and XII collagens.
|
10 | B0S602 (/IMP) B0S602 (/IMP) B3DGZ1 (/IMP) B3DGZ1 (/IMP) F1RBP8 (/IMP) F1RBP8 (/IMP) O93405 (/IMP) O93405 (/IMP) O93406 (/IMP) O93406 (/IMP) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
9 | P11276 (/ISO) P11276 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Basement membrane GO:0005604
A collagen-containing extracellular matrix consisting of a thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
|
8 | F1NJT3 (/IDA) F1NJT3 (/IDA) P04937 (/IDA) P04937 (/IDA) P11276 (/IDA) P11276 (/IDA) Q90611 (/IDA) Q90611 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
8 | F1NJT3 (/IDA) F1NJT3 (/IDA) P22897 (/IDA) P33434 (/IDA) P33434 (/IDA) P33434 (/IDA) P33434 (/IDA) Q13018 (/IDA) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
6 | F1NJT3 (/IDA) F1NJT3 (/IDA) P02751 (/IDA) P02751 (/IDA) Q90611 (/IDA) Q90611 (/IDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
5 | P02751 (/HDA) P02751 (/HDA) P14780 (/HDA) P14780 (/HDA) P14780 (/HDA) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
5 | F1NJT3 (/IDA) F1NJT3 (/IDA) Q13018 (/IDA) Q61830 (/IDA) Q61830 (/IDA) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
5 | P02751 (/HDA) P02751 (/HDA) P14780 (/HDA) P14780 (/HDA) P14780 (/HDA) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
5 | B5X4C7 (/IDA) B5X4C7 (/IDA) B5X4C7 (/IDA) P02751 (/IDA) P02751 (/IDA) |
Hrd1p ubiquitin ligase ERAD-L complex GO:0000839
A multiprotein complex that recognizes and ubiquitinates proteins with misfolded luminal domains during ER-associated protein degradation (ERAD). In S. cerevisiae, this complex contains the ubiquitin ligase Hrd1p.
|
4 | Q80Z70 (/ISS) Q9ESM7 (/ISS) Q9ESM7 (/ISS) Q9Z2G6 (/ISS) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
4 | P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) P08253 (/TAS) |
Cell GO:0005623
The basic structural and functional unit of all organisms. Includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope.
|
4 | F1NJT3 (/IDA) F1NJT3 (/IDA) Q90611 (/IDA) Q90611 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
4 | F1NJT3 (/IDA) F1NJT3 (/IDA) P33436 (/IDA) P33436 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
4 | P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) P33434 (/ISO) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
4 | Q80Z70 (/ISS) Q9ESM7 (/ISS) Q9ESM7 (/ISS) Q9Z2G6 (/ISS) |
Sarcomere GO:0030017
The repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs.
|
4 | P33434 (/IDA) P33434 (/IDA) P33434 (/IDA) P33434 (/IDA) |
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
|
4 | P02751 (/IDA) P02751 (/IDA) P11276 (/IDA) P11276 (/IDA) |
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
|
4 | P04937 (/TAS) P04937 (/TAS) P11276 (/TAS) P11276 (/TAS) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
3 | Q61830 (/ISO) Q61830 (/ISO) Q62028 (/ISO) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
3 | Q61830 (/TAS) Q61830 (/TAS) Q64449 (/TAS) |
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
3 | P50282 (/IDA) P50282 (/IDA) P50282 (/IDA) |
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
3 | P41245 (/ISO) P41245 (/ISO) P41245 (/ISO) |
Tertiary granule lumen GO:1904724
Any membrane-enclosed lumen that is part of a tertiary granule.
|
3 | P14780 (/TAS) P14780 (/TAS) P14780 (/TAS) |
Ficolin-1-rich granule lumen GO:1904813
Any membrane-enclosed lumen that is part of a ficolin-1-rich granule.
|
3 | P14780 (/TAS) P14780 (/TAS) P14780 (/TAS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
2 | P02751 (/NAS) P02751 (/NAS) |
Fibrinogen complex GO:0005577
A highly soluble, elongated protein complex found in blood plasma and involved in clot formation. It is converted into fibrin monomer by the action of thrombin. In the mouse, fibrinogen is a hexamer, 46 nm long and 9 nm maximal diameter, containing two sets of nonidentical chains (alpha, beta, and gamma) linked together by disulfide bonds.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Fibrinogen complex GO:0005577
A highly soluble, elongated protein complex found in blood plasma and involved in clot formation. It is converted into fibrin monomer by the action of thrombin. In the mouse, fibrinogen is a hexamer, 46 nm long and 9 nm maximal diameter, containing two sets of nonidentical chains (alpha, beta, and gamma) linked together by disulfide bonds.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Basement membrane GO:0005604
A collagen-containing extracellular matrix consisting of a thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Interstitial matrix GO:0005614
A type of extracellular matrix found in interstitial connective tissue, characterized by the presence of fibronectins, proteoglycans, and types I, III, V, VI, VII and XII collagens.
|
2 | F1NJT3 (/IDA) F1NJT3 (/IDA) |
Endoplasmic reticulum lumen GO:0005788
The volume enclosed by the membranes of the endoplasmic reticulum.
|
2 | P02751 (/TAS) P02751 (/TAS) |
Endoplasmic reticulum-Golgi intermediate compartment GO:0005793
A complex system of membrane-bounded compartments located between endoplasmic reticulum (ER) and the Golgi complex, with a distinctive membrane protein composition; involved in ER-to-Golgi and Golgi-to-ER transport.
|
2 | P02751 (/IDA) P02751 (/IDA) |
Endoplasmic reticulum-Golgi intermediate compartment GO:0005793
A complex system of membrane-bounded compartments located between endoplasmic reticulum (ER) and the Golgi complex, with a distinctive membrane protein composition; involved in ER-to-Golgi and Golgi-to-ER transport.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
2 | Q62028 (/ISO) Q64449 (/ISO) |
Endosome membrane GO:0010008
The lipid bilayer surrounding an endosome.
|
2 | Q61830 (/ISO) Q61830 (/ISO) |
Endosome membrane GO:0010008
The lipid bilayer surrounding an endosome.
|
2 | Q61830 (/ISS) Q61830 (/ISS) |
Apical plasma membrane GO:0016324
The region of the plasma membrane located at the apical end of the cell.
|
2 | P11276 (/IDA) P11276 (/IDA) |
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Platelet alpha granule lumen GO:0031093
The volume enclosed by the membrane of the platelet alpha granule.
|
2 | P02751 (/TAS) P02751 (/TAS) |
Basal part of cell GO:0045178
The region of a cell situated near the base. For example, in a polarized epithelial cell, the basal surface rests on the basal lamina that separates the epithelium from other tissue.
|
2 | F1NJT3 (/IDA) F1NJT3 (/IDA) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
2 | F1NJT3 (/IDA) F1NJT3 (/IDA) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
2 | P11276 (/ISO) P11276 (/ISO) |
Blood microparticle GO:0072562
A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
|
2 | P02751 (/HDA) P02751 (/HDA) |
Supramolecular fiber GO:0099512
A polymer consisting of an indefinite number of protein or protein complex subunits that have polymerised to form a fiber-shaped structure.
|
2 | F1NJT3 (/IDA) F1NJT3 (/IDA) |
Hrd1p ubiquitin ligase complex GO:0000836
A multiprotein complex that recognizes and ubiquitinates proteins with misfolded luminal and membrane domains during ER-associated protein degradation (ERAD). In S. cerevisiae, this complex contains the ubiquitin ligase Hrd1p. In mammals, this complex contains the ubiquitin ligase HRD1 (Synoviolin) or AMFR (gp78).
|
1 | Q9UBV2 (/TAS) |
Hrd1p ubiquitin ligase ERAD-L complex GO:0000839
A multiprotein complex that recognizes and ubiquitinates proteins with misfolded luminal domains during ER-associated protein degradation (ERAD). In S. cerevisiae, this complex contains the ubiquitin ligase Hrd1p.
|
1 | Q9UBV2 (/IMP) |
Hrd1p ubiquitin ligase ERAD-L complex GO:0000839
A multiprotein complex that recognizes and ubiquitinates proteins with misfolded luminal domains during ER-associated protein degradation (ERAD). In S. cerevisiae, this complex contains the ubiquitin ligase Hrd1p.
|
1 | Q9Z2G6 (/ISO) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
1 | Q13018 (/ISS) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
1 | Q9UBV2 (/IDA) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
1 | Q9Z2G6 (/ISO) |
Endoplasmic reticulum membrane GO:0005789
The lipid bilayer surrounding the endoplasmic reticulum.
|
1 | Q9UBV2 (/TAS) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | P22897 (/TAS) |
Focal adhesion GO:0005925
Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.
|
1 | Q9UBG0 (/HDA) |
Endosome membrane GO:0010008
The lipid bilayer surrounding an endosome.
|
1 | P22897 (/IDA) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
1 | Q9UBG0 (/HDA) |
Derlin-1 retrotranslocation complex GO:0036513
A protein complex that functions in the retrotranslocation step of ERAD (ER-associated protein degradation), and includes at its core Derlin-1 oligomers forming a retrotranslocation channel.
|
1 | Q9UBV2 (/IDA) |
Derlin-1 retrotranslocation complex GO:0036513
A protein complex that functions in the retrotranslocation step of ERAD (ER-associated protein degradation), and includes at its core Derlin-1 oligomers forming a retrotranslocation channel.
|
1 | Q9Z2G6 (/ISO) |
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | Q13018 (/IDA) |
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | Q62028 (/ISO) |